Kathlyn Parker and colleague have reported in JACS on a synthesis of arabilin, an androgen receptor antagonist that can potentially treat prostate cancer (IC50 of 11 micromolar towards AR). A 1,7-hydride shift occured in their key Stille coupling to afford the correct isomer.

